Pharmabiz

Lupin receives EIR from US FDA for its Nagpur injectable facility

Lupin receives EIR from US FDA for its Nagpur injectable facility: Our Bureau, Mumbai Wednesday, December 17, 2025, 13:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) annou ...
Pharmabiz

Biocon Biologics recognized as Asia IP Elite for 2025 by IAM

Biocon Biologics, a fully integrated global biosimilars company and subsidiary of Biocon has been recognized as an Asia IP Elite for 2025 by IAM (Intellectual Asset Management), the world’s leading ...
Pharmabiz

Johnson & Johnson’s sNDA for Akeega gets US FDA approval to treat patients with BRCA2-mutated mCSPC

Johnson & Johnson’s sNDA for Akeega gets US FDA approval to treat patients with BRCA2-mutated mCSPC: Horsham, Pennsylvania Wednesday, December 17, 2025, 13:00 Hrs [IST] Johnson ...
Pharmabiz

Glenmark enters collaboration and distribution agreement with Jiangsu Hansoh Pharma for Aumolertinib, a third-generation GFR-TKI to treat NSCLC

Glenmark enters collaboration and distribution agreement with Jiangsu Hansoh Pharma for Aumolertinib, a third-generation GFR-TKI to treat NSCLC: Our Bureau, Mumbai Wednesday, Dece ...
Pharmabiz

ALZpath & Siemens Healthineers ink licensing agreement to advance global access to blood-based Alzheimer’s disease diagnostic testing

ALZpath & Siemens Healthineers ink licensing agreement to advance global access to blood-based Alzheimer’s disease diagnostic testing: Carlsbad, California Wednesday, December 1 ...
Pharmabiz

TempraMed Technologies’ medical-storage system VIVI Box receives South Korean patent; strengthens global IP position

TempraMed Technologies’ medical-storage system VIVI Box receives South Korean patent; strengthens global IP position: Vancouver, British Columbia Wednesday, December 17, 2025, 1 ...
Pharmabiz

CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic

CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic: Our Bureau, Bengaluru ...
Pharmabiz

Bristol Myers Squibb opens a new AI-powered content hub, ‘Mosaic’, in Mumbai

Bristol Myers Squibb, one of the world’s largest biopharmaceutical companies, and Accenture, a global professional services ...
Pharmabiz

AstraZeneca’s Saphnelo approved in EU for subcutaneous self-administration as a new pre-filled pen for systemic lupus erythematosus

AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on ...
Pharmabiz

UK MHRA approves GSK’s Exdensur to treat asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps

GSK plc announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications: ...
Pharmabiz

ICMR reopens the call for EoI for development of mAbs against Nipah virus due to inadequate responses

ICMR reopens the call for EoI for development of mAbs against Nipah virus due to inadequate responses: Shardul Nautiyal, Mumbai Wednesday, December 17, 2025, 08:00 Hrs [IST] Due t ...
Pharmabiz

AKCDA seeks DCGI’s intervention in fake drug scandal at Kerala's discount pharmacies

AKCDA seeks DCGI’s intervention in fake drug scandal at Kerala's discount pharmacies: Peethaambaran Kunnathoor, Chennai Wednesday, December 17, 2025, 08:00 Hrs [IST] The All Ker ...